C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
CCANF Equity

CCANF

OTCMKTS · CCANF

—
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
41/100 composite
Fundamentals40
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Canada House Wellness earns a Neutral rating with 3/5 conviction, anchored by a 40.8 composite that reflects limited differentiation across the framework. Regulatory is the strongest pillar at 49, supported by an 80 enforcement subscore and a jurisdiction posture at 50, despite a weak cadence subscore of 25. Fundamentals and market each contribute 40, but both scores reflect unavailable operating and quotation inputs rather than demonstrated business strength. Editorial contributes 30, the lowest pillar result, following no newsroom or brief activity. The resulting profile supports balance rather than directional conviction: regulatory standing provides stability, while sparse financial, trading, and editorial evidence caps upside attribution.

Licensed fundamentals data provide no current basis for measuring revenue growth, gross margin, operating margin, EBITDA, net income, or financial condition. Consequently, the fundamentals pillar cannot establish whether commercial performance is accelerating, profitability is improving, or capital capacity is changing. Institutional pricing feeds likewise provide no available quote, preventing assessment of price momentum, volatility, liquidity, or valuation. Filing cadence remains the clearest weakness inside the leading pillar: primary regulatory filings show no latest filing date, no events during the past 90 days, and no events during the past 180 days. The absence of enforcement hits reinforces the elevated enforcement subscore, but limited filing activity constrains confirmation of ongoing compliance and corporate progress. CIN newsroom coverage also records no newsroom hits and no brief hits, matching both editorial subscores at 30.

The forward catalyst rests entirely on regulatory disclosure because that pillar already delivers the highest contribution and contains the clearest path to a higher composite. A new primary regulatory filing would directly address the 25 cadence subscore, establish a current disclosure reference point, and create evidence capable of informing the presently unverified fundamentals and market pillars. Continued absence of enforcement hits preserves the strongest regulatory driver, while fresh filings enable the rating framework to distinguish operational progress from data scarcity. The single most important signal to watch is the appearance and content of the next primary regulatory filing.

Scored: 2026-10-16Valid through: 2026-11-30Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Phone
1-877-685-2266
Website
Company website
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for CCANF (CCANF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CCANF (CCANF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CCANF are maintained by Cannabis Investor News and refreshed throughout the trading day.